FWIW Raw data has been out for awhile but official study paper now up as an advance publication (April 2020) at jstage for Epanova (AstraZeneca) 12 week/52 week study (Japan). (Epanova discontinued by $AZN earlier this year) $AMRN
https://t.co/VPoDhpO7On https://t.co/eMUXUHwKlk
@JPSwcpmc Yes! Looking fwd to the reveal on REDUCE-IT data and hoping to hear an update on their EVAPORATE trial i.e enrollment. EVAPORATE has an efficacy readout at 9 months, I believe. Should align with these results: https://t.co/RnMKcptYYI $AMRN